Logo (pure-white background + navy borde

Diverse Health Hub

  • Facebook
  • Twitter
  • Instagram

© 2020 Diverse Health Hub, LLC

Renal Medullary Carcinoma

Renal medullary carcinoma (RMC) is a very rare, aggressive, difficult to treat kidney cancer that predominantly impacts young people of African descent carrying the sickle cell trait or sickle cell disease. With many disparities already existing in sickle cell disease, Diverse Health Hub has made it our priority to spotlight this rare cancer for patients and families impacted by RMC.

What is RMC?

This featured video provides a detailed look into RMC, its physiology, and its effects on a young athlete.

Renal Medullary Carcinoma Programs

Screen Shot 2019-12-15 at 10_edited.jpg

What Health Disparities Exist for Patients with Renal Medullary Carcinoma?

Dr. Pavlos Msaouel discusses disparities that exist for patients with Renal Medullary Carcinoma (RMC). Young African Americans as well as Nigerians on a global scale are underdiagnosed due to lack of resources such as health insurance and research reports.

Screen Shot 2019-12-15 at 10_edited.jpg

Are Sickle Cell Disease Patients More Susceptible to Renal Medullary Carcinoma?

Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center discusses whether patients with sickle cell disease or who carry the sickle cell trait may be at increased risk for renal medullary carcinoma (RMC).

Screen Shot 2019-12-15 at 10_edited.jpg

What is Renal Medullary Carcinoma?

Respected oncologist, Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center, explains what renal medullary carcinoma (RMC) is and what symptoms typically present at diagnosis.

Thank you for visiting our Renal Medullary Carcinoma Focus Area.

We are working hard to bring you meaningful educational content. Please check back or be sure to sign up for our newsletter for more information.